Healthcare Sector

Biomm's Nova Lima production facility is dedicated to the development, manufacture, and commercialization of complex biotech and biosimilar medicinal products.

In terms of imminent development in Uttar Pradesh, he stated that the business is looking to expand by another 300-odd beds going forward.

The company's board has decided not to declare an interim dividend for fiscal year 2023-24.

India is the world's largest provider of generic medications, accounting for around 20% of worldwide supply.

Indraprastha Medical maintains two hospitals: one in New Delhi and one in Noida. It is backed by the Delhi government and Apollo Hospitals.

The business would work together with the USFDA to resolve the concerns, it announced.

The company's board of directors will meet on Tuesday, May 7, 2024, to consider and approve the audited standalone and consolidated financial results.

The pharmaceutical stock was offered on public markets in May of last year, at a 20% premium to its issue price of ₹1,080.

Rodolfo Hrosz, Managing Director of Sanofi India Limited, emphasized that their CNS products hold leading positions within their respective categories.

He will be located in Mumbai and would be in charge of Lupin's technical operations.